Skip to main content

Advertisement

Log in

Catechol-O-methyltransferase Val158Met polymorphism in breast cancer risk

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ding H, Fu Y, Chen W, Wang Z (2010) COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies. Breast Cancer Res Treat 123:265–270

    Article  PubMed  CAS  Google Scholar 

  2. Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q (2010) Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat 121:719–725

    Article  PubMed  CAS  Google Scholar 

  3. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY (1999) Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59:4870–4875

    PubMed  CAS  Google Scholar 

  4. Bergman-Jungeström M, Wingren S (2001) Catechol-O-methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. Br J Cancer 85:859–862

    Article  PubMed  Google Scholar 

  5. Ahsan H, Chen Y, Whittemore AS, Kibriya MG, Gurvich I, Senie RT, Santella RM (2004) A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res Treat 85:121–131

    Article  PubMed  CAS  Google Scholar 

  6. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA (2004) Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96:936–945

    Article  PubMed  CAS  Google Scholar 

  7. Gaudet MM, Bensen JT, Schroeder J, Olshan AF, Terry MB, Eng SM, Teitelbaum SL, Britton JA, Lehman TA, Neugut AI, Ambrosone CB, Santella RM, Gammon MD (2006) Catechol-Omethyltransferase haplotypes and breast cancer among women on Long Island, New York. Breast Cancer Res Treat 99:235–240

    Article  PubMed  CAS  Google Scholar 

  8. The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2010) Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 119:463–474

    Article  Google Scholar 

  9. Yadav S, Singhal NK, Singh V, Rastogi N, Srivastava PK, Singh MP (2009) Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women. Dis Markers 27:203–210

    PubMed  CAS  Google Scholar 

  10. Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, Ahn SH, Noh DY, Choe KJ, Jang IJ, Shin SG, Strickland PT, Hirvonen A, Kang D (2001) Relationship between the Val108/158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 11:279–286

    Article  PubMed  CAS  Google Scholar 

  11. Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Laird NM, Khuhaprema T, Brennan P, Boffetta P, Yoshida T (2009) Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer 125:837–843

    Article  PubMed  CAS  Google Scholar 

  12. Xi B, Wang C, Wang R, Huang YB (2010) FTO gene polymorphisms are associated with obesity and type 2 diabetes in East Asian populations: an update. Obesity (Silver Spring). doi:10.1038/oby.2010.1139

  13. Sun L, Xi B, Yu L, Gao XC, Shi DJ, Yan YK, Xu DJ, Han Q, Wang C (2010) Association of glutathione S-transferases polymorphisms (GSTM1 and GSTT1) with senile cataract: a meta-analysis. Invest Ophthalmol Vis Sci 51:6381–6386

    Google Scholar 

References for Rebuttal Letter

  1. Xi B, Zeng T, Liu W (2010) Catechol-O-methyltransferase Val158Met polymorphism in breast cancer risk. Breast Cancer Res Treat. doi:10.1007/s10549-010-1337-6

  2. Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q (2010) Lack of association betweencatechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat 121:719–725

    Article  PubMed  CAS  Google Scholar 

  3. Ding H, Fu Y, Chen W, Wang Z (2010) COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies. Breast Cancer Res Treat 123:265–270

    Article  PubMed  CAS  Google Scholar 

  4. Yadav S, Singhal NK, Singh V, Rastogi N, Srivastava PK, Singh MP (2009) Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women. Dis Markers 27:203–210

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bo Xi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xi, B., Zeng, T. & Liu, W. Catechol-O-methyltransferase Val158Met polymorphism in breast cancer risk. Breast Cancer Res Treat 126, 839–841 (2011). https://doi.org/10.1007/s10549-010-1337-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-1337-6

Keywords

Navigation